Dietary Antioxidants and Thiol Disulfide Homeostasis in T2DM
NCT ID: NCT05688631
Last Updated: 2023-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
87 participants
OBSERVATIONAL
2021-01-03
2021-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes
NCT00845130
Antioxidant Treatment of Type 2 Diabetes
NCT00609102
Probiotic Effects in Type 2 Diabetes
NCT07330388
Evaluation of the Relationship Between Serum Selenium Level and Glycemic Control in Pregnant Patients*
NCT05823337
Effect of Anthocyanins on Metabolic Profiles in Subjects With Pre-diabetes
NCT02689765
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic participants (case group)
Participants diagnosed with type 2 diabetes mellitus
Dietary antioxidant intake
Decreased intake of dietary antioxidant is associated with decreased thiol disulfide homeostasis parameters in diabetic and healthy participants.
Healthy participants (control group)
Participants not diagnosed with type 2 diabetes mellitus or any other chronic diseases
Dietary antioxidant intake
Decreased intake of dietary antioxidant is associated with decreased thiol disulfide homeostasis parameters in diabetic and healthy participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary antioxidant intake
Decreased intake of dietary antioxidant is associated with decreased thiol disulfide homeostasis parameters in diabetic and healthy participants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetes age for a maximum of 5 years
* Body mass index (BMI)\<30 kg/m\^2
* Received and applied medical nutrition therapy and metformin therapy
* Body mass index (BMI) \<30 kg/m\^2
Exclusion Criteria
* Developing diabetes-specific complications
* Smoking tobacco
* Consuming alcohol
* Having end-stage chronic renal failure
* Receiving chemotherapy and/or radiotherapy
* Being in menopause, pregnant and/or lactation period
* Using antioxidant vitamin and mineral supplements
* Smoking tobacco
* Using alcohol
* Having any chronic disease
* Having end-stage chronic renal failure
* Receiving chemotherapy and/or radiotherapy
* Being in menopausal, pregnant and/or lactation period,
* Using antioxidant vitamin and mineral supplements
* Following any diet program
30 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baskent University
OTHER
Ankara Yildirim Beyazıt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rahime Evra KARAKAYA
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Yıldırım Beyazıt University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AnkaraYBU-KARAKAYA001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.